Neovasc Inc. (TSE:NVC), a medical device stock, rose following a securities class action lawsuit ruling
Sean Mason | November 23, 2016 | SmallCapPower
A favourable court decision was good news for a medical device stock Wednesday. Here’s some small stocks making big moves on Wednesday, November 23, 2016 (as of 4 pm EST):
Medical device stock Neovasc Inc. (TSE:NVC) climbed 8% to $0.70 on Wednesday after announcing that the United States District Court for the District of Massachusetts ruled in favor of the Company and its officers on all claims in the case of Grobler vs. Neovasc Inc, et al., Civil Action No. 16-11038-RGS, a putative securities class action that was filed on June 6, 2016, against Neovasc and certain of the Company’s officers.
As well, shares of Moovly Media Inc. (CVE:MVY) jumped 61% to $0.25 as the Cloud-based multimedia platform provider said it has exceeded the one million registered user mark, with momentum building over the past three months.
DuSolo Fertilizers Inc. (CVE:DSF), meanwhile, provided a corporate update, stating that it has now processed and sold all its stockpiles of both product and run-of-mine material at the Campos Belos Plant in Brazil. Total sales to November 17, 2016, of both 12% and 15% Phosphate DANF are 27,868 tonnes. The Company currently has signed forward sales contracts to deliver an additional 9,306 tonnes. DuSolo Fertilizers stock moved up 25% to $0.05 following the announcement.
Hi, did you know SmallCapPower accepts blog submissions? You can contact me here
DISCLAIMER
The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. The Reader should apply his/her own judgment in making any use of any Content, including, without limitation, the use of any information contained therein as the basis for any conclusions. The Reader bears responsibility for his/her own investment research and decisions. Before making any investment decision, it is strongly recommended that you seek outside advice from a qualified investment advisor. SmallCapPower/Ubika Research does not provide or guarantee any financial, legal, tax, or accounting advice or advice regarding the suitability, profitability, or potential value of any particular investment, security, or information source. Ubika and/or its affiliates and/or their respective officers, directors or employees may from time to time acquire, hold or sell securities and/or commodities and/or commodity futures contracts in certain underlying companies mentioned in this site and which may also be clients of Ubika’s affiliates. In such instances, Ubika and/or its affiliates and/or their respective officers, directors or employees will use all reasonable efforts to avoid engaging in activities that would lead to conflicts of interest and Ubika and/or its affiliates will use all reasonable efforts to comply with conflicts of interest disclosures and regulations to minimize the conflict.
